{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:09:13Z","timestamp":1783901353682,"version":"3.55.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08160-8","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:37:45Z","timestamp":1779107865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycolysis-driven cancer-associated fibroblasts shape T-Cell exclusion via the CXCL16\u2013CXCR6 Axis: a metabolic-chemokine mechanism in tumor immunity"],"prefix":"10.1186","volume":"24","author":[{"given":"Yunya","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guichen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinXiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1587-0362","authenticated-orcid":false,"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"8160_CR1","doi-asserted-by":"publisher","unstructured":"Abu El-Asrar A, Nawaz MI, Ahmad A, De Zutter A, Siddiquei MM, Blanter M, et al. Evaluation of proteoforms of the transmembrane chemokines CXCL16 and CX3CL1, their receptors, and their processing metalloproteinases ADAM10 and ADAM17 in proliferative diabetic retinopathy. Front Immunol. 2021;11:- 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.601639.","DOI":"10.3389\/fimmu.2020.601639"},{"key":"8160_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eclinm.2021.101134","volume":"41","author":"F Li","year":"2021","unstructured":"Li F, Li C, Cai X, Xie Z, Zhou L, Cheng B, et al. The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: a systematic review and meta-analysis. eClinicalmedicine. 2021;41:41. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101134.","journal-title":"eClinicalmedicine"},{"key":"8160_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-3-030-38862-1_6","volume-title":"Tumor microenvironment","author":"SI Pai","year":"2020","unstructured":"Pai SI, Cesano A, Marincola FM. The paradox of cancer immune exclusion: immune Oncology next frontier. In: Lee PP, Marincola FM, editors. Tumor microenvironment. Cham: Springer International Publishing; 2020. p. 173\u201395."},{"key":"8160_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coi.2015.01.011","volume":"33","author":"E Lanitis","year":"2015","unstructured":"Lanitis E, Irving M, Coukos G. Targeting the tumor vasculature to enhance T cell activity. Curr Opin Immunol. 2015;33:55\u201363. https:\/\/doi.org\/10.1016\/j.coi.2015.01.011.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"8160_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","volume":"9","author":"MB Schaaf","year":"2018","unstructured":"Schaaf MB, Garg AD, Agostinis P. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy. Cell Death Dis. 2018;9(2):115. https:\/\/doi.org\/10.1038\/s41419-017-0061-0.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8160_CR6","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","volume":"14","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Todd L, Huang L, Noguera-Ortega E, Lu Z, Huang L, et al. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat Commun. 2023;14(1):5110. https:\/\/doi.org\/10.1038\/s41467-023-40850-5.","journal-title":"Nat Commun"},{"key":"8160_CR7","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig C, Jones JO, Kraman M, Wells RJ, Deonarine A, Chan DS, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A. 2013;110:20212\u201317.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"8160_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"8160_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394.","journal-title":"Nat Med"},{"key":"8160_CR10","doi-asserted-by":"publisher","unstructured":"Ke H, Li P, Li Z, Zeng X, Zhang C, Luo S, et al. Immune profiling of the macroenvironment in colorectal cancer unveils systemic dysfunction and plasticity of immune cells. Clin Transl Med. 2025;15(2):e70175. https:\/\/doi.org\/10.1002\/ctm2.70175.","DOI":"10.1002\/ctm2.70175"},{"issue":"4","key":"8160_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.drudis.2021.01.002","volume":"26","author":"S Kumar","year":"2021","unstructured":"Kumar S, Singh SK, Rana B, Rana A. Tumor-infiltrating CD8+ T cell antitumor efficacy and exhaustion: molecular insights. Drug Discov. Today. 2021;26(4):951\u201367. https:\/\/doi.org\/10.1016\/j.drudis.2021.01.002.","journal-title":"Drug Discov. Today Today"},{"issue":"1","key":"8160_CR12","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1038\/s41467-024-53908-9","volume":"15","author":"A Forsthuber","year":"2024","unstructured":"Forsthuber A, Aschenbrenner B, Korosec A, Jacob T, Annusver K, Krajic N, et al. Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancy. Nat Commun. 2024;15(1):9678. https:\/\/doi.org\/10.1038\/s41467-024-53908-9.","journal-title":"Nat Commun"},{"key":"8160_CR13","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009;8:3984\u20134001.","journal-title":"Cell Cycle"},{"issue":"15","key":"8160_CR14","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.4161\/cc.10.15.16585","volume":"10","author":"UE Martinez-Outschoorn","year":"2011","unstructured":"Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C, Pavlides S, et al. Cancer cells metabolically \u201cfertilize\u201d the tumor microenvironment with hydrogen peroxide, driving the Warburg effect. Cell Cycle. 2011;10(15):2504\u201320. https:\/\/doi.org\/10.4161\/cc.10.15.16585.","journal-title":"Cell Cycle"},{"issue":"34","key":"8160_CR15","doi-asserted-by":"publisher","first-page":"57813","DOI":"10.18632\/oncotarget.18175","volume":"8","author":"Y Fu","year":"2017","unstructured":"Fu Y, Liu S, Yin S, Niu W, Xiong W, Tan M, et al. The reverse Warburg effect is likely to be an Achilles\u2019 heel of cancer that can be exploited for cancer therapy. Oncotarget. 2017;8(34):57813\u201325. https:\/\/doi.org\/10.18632\/oncotarget.18175.","journal-title":"Oncotarget"},{"issue":"1","key":"8160_CR16","doi-asserted-by":"publisher","first-page":"13050","DOI":"10.1038\/ncomms13050","volume":"7","author":"R Allaoui","year":"2016","unstructured":"Allaoui R, Bergenfelz C, Mohlin S, Hagerling C, Salari K, Werb Z, et al. Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nat Commun. 2016;7(1):13050. https:\/\/doi.org\/10.1038\/ncomms13050.","journal-title":"Nat Commun"},{"issue":"1","key":"8160_CR17","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","volume":"15","author":"MT Broz","year":"2024","unstructured":"Broz MT, Ko EY, Ishaya K, Xiao J, De Simone M, Hoi XP, et al. Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas. Nat Commun. 2024;15(1):2498. https:\/\/doi.org\/10.1038\/s41467-024-46504-4.","journal-title":"Nat Commun"},{"key":"8160_CR18","doi-asserted-by":"publisher","unstructured":"Chia T-Y, Billingham LK, Boland L, Katz JL, Arrieta VA, Shireman J, et al. The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context. Front. Immunol. 2024;14:- 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1331287.","DOI":"10.3389\/fimmu.2023.1331287"},{"key":"8160_CR19","doi-asserted-by":"publisher","unstructured":"Mabrouk N, Tran T, Sam I, Pourmir I, Gruel N, Granier C, et al. CXCR6 expressing T cells: functions and role in the control of tumors. Front Immunol. 2022;13:- 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1022136.","DOI":"10.3389\/fimmu.2022.1022136"},{"key":"8160_CR20","doi-asserted-by":"publisher","unstructured":"Eales KL, Hollinshead KER, Tennant DA. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis. 2016;5(1):e190\u2013190. https:\/\/doi.org\/10.1038\/oncsis.2015.50.","DOI":"10.1038\/oncsis.2015.50"},{"issue":"12","key":"8160_CR21","doi-asserted-by":"publisher","first-page":"9519","DOI":"10.1074\/jbc.M010144200","volume":"276","author":"C Chen","year":"2001","unstructured":"Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. Regulation of glut1 mRNA by Hypoxia-inducible factor-1: interaction between H-ras and hypoxia*. J Biol Chem. 2001;276(12):9519\u201325. https:\/\/doi.org\/10.1074\/jbc.M010144200.","journal-title":"J Biol Chem"},{"key":"8160_CR22","doi-asserted-by":"crossref","unstructured":"Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Investigation. 2022;132.","DOI":"10.1172\/JCI159839"},{"issue":"8","key":"8160_CR23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.celrep.2015.02.006","volume":"10","author":"D Zhang","year":"2015","unstructured":"Zhang D, Wang Y, Shi Z, Liu J, Sun P, Hou X, et al. Metabolic reprogramming of cancer-associated fibroblasts by IDH3\u03b1 downregulation. Cell Rep. 2015;10(8):1335\u201348. https:\/\/doi.org\/10.1016\/j.celrep.2015.02.006.","journal-title":"Cell Rep"},{"issue":"16","key":"8160_CR24","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.4161\/cc.25794","volume":"12","author":"D Martins","year":"2013","unstructured":"Martins D, Be\u00e7a F, Sousa B, Baltazar F, Paredes J, Schmitt F. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma. Cell Cycle. 2013;12(16):2684\u201390. https:\/\/doi.org\/10.4161\/cc.25794.","journal-title":"Cell Cycle"},{"issue":"4","key":"8160_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/bcr2892","volume":"13","author":"F Sotgia","year":"2011","unstructured":"Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Lisanti MP. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res. 2011;13(4):213. https:\/\/doi.org\/10.1186\/bcr2892.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"8160_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12943-018-0882-1","volume":"17","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhao H, Li Y, Xia D, Yang L, Ma Y, et al. The role of YAP\/TAZ activity in cancer metabolic reprogramming. Mol Cancer. 2018;17(1):134. https:\/\/doi.org\/10.1186\/s12943-018-0882-1.","journal-title":"Mol Cancer"},{"key":"8160_CR27","doi-asserted-by":"publisher","unstructured":"Ge H, Tian M, Pei Q, Tan F, Pei H. Extracellular matrix stiffness: new areas affecting cell metabolism. Front Oncol. 2021;11:- 2021. https:\/\/doi.org\/10.3389\/fonc.2021.631991.","DOI":"10.3389\/fonc.2021.631991"},{"key":"8160_CR28","doi-asserted-by":"crossref","unstructured":"Wang JX, Choi SYC, Niu X, Kang N, Xue H, Killam J, et al. Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. In: International journal of molecular sciences. Vol. 21. 2020. p. 8363.","DOI":"10.3390\/ijms21218363"},{"key":"8160_CR29","doi-asserted-by":"publisher","unstructured":"Gu X-Y, Yang J-L, Lai R, Zhou Z-J, Tang D, Hu L, et al. Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Front Immunol. 2025;16:- 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1563303.","DOI":"10.3389\/fimmu.2025.1563303"},{"issue":"12","key":"8160_CR30","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/2326-6066.CIR-20-0235","volume":"8","author":"SS Akhand","year":"2020","unstructured":"Akhand SS, Liu Z, Purdy SC, Abdullah A, Lin H, Cresswell GM, et al. Pharmacologic inhibition of FGFR modulates the metastatic immune microenvironment and promotes response to immune checkpoint blockade. Cancer Immunol Res. 2020;8(12):1542\u201353. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0235.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"8160_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms22020843","volume":"22","author":"J Korbecki","year":"2021","unstructured":"Korbecki J, Kojder K, Kapczuk P, Kupnicka P, Gawro\u0144ska-Szklarz B, Gutowska I, et al. The effect of Hypoxia on the expression of CXC chemokines and CXC chemokine receptors\u2014a review of literature. IJMS. 2021;22(2):843. https:\/\/doi.org\/10.3390\/ijms22020843.","journal-title":"IJMS"},{"issue":"9","key":"8160_CR32","doi-asserted-by":"publisher","first-page":"107701","DOI":"10.1016\/j.celrep.2020.107701","volume":"31","author":"LM Becker","year":"2020","unstructured":"Becker LM, O\u2019Connell JT, Vo AP, Cain MP, Tampe D, Bizarro L, et al. Epigenetic reprogramming of cancer-associated fibroblasts deregulates glucose metabolism and facilitates progression of breast cancer. Cell Rep. 2020;31(9):107701. https:\/\/doi.org\/10.1016\/j.celrep.2020.107701.","journal-title":"Cell Rep"},{"issue":"1","key":"8160_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/JP280572","volume":"599","author":"SJ Kierans","year":"2021","unstructured":"Kierans SJ, Taylor CT. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol. 2021;599(1):23\u201337. https:\/\/doi.org\/10.1113\/JP280572.","journal-title":"J Physiol"},{"issue":"1","key":"8160_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13073-024-01367-8","volume":"16","author":"S-Y Jing","year":"2024","unstructured":"Jing S-Y, Liu D, Feng N, Dong H, Wang H-Q, Yan X, et al. Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma. Genome Med. 2024;16(1):98. https:\/\/doi.org\/10.1186\/s13073-024-01367-8.","journal-title":"Genome Med"},{"issue":"11","key":"8160_CR35","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","volume":"12","author":"JA Grout","year":"2022","unstructured":"Grout JA, Sirven P, Leader AM, Maskey S, Hector E, Puisieux I, et al. Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors. Cancer Discov. 2022;12(11):2606\u201325. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1714.","journal-title":"Cancer Discov"},{"issue":"7","key":"8160_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022;3(7):793\u2013807. https:\/\/doi.org\/10.1038\/s43018-022-00411-z.","journal-title":"Nat Cancer"},{"issue":"1","key":"8160_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","volume":"22","author":"C Ma","year":"2023","unstructured":"Ma C, Yang C, Peng A, Sun T, Ji X, Mi J, et al. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol Cancer. 2023;22(1):170. https:\/\/doi.org\/10.1186\/s12943-023-01876-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"8160_CR38","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","volume":"14","author":"R Arora","year":"2023","unstructured":"Arora R, Cao C, Kumar M, Sinha S, Chanda A, McNeil R, et al. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. Nat Commun. 2023;14(1):5029. https:\/\/doi.org\/10.1038\/s41467-023-40271-4.","journal-title":"Nat Commun"},{"issue":"2","key":"8160_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1158\/0008-5472.CAN-23-1448","volume":"84","author":"C Li","year":"2024","unstructured":"Li C, Guo H, Zhai P, Yan M, Liu C, Wang X, et al. Spatial and single-cell transcriptomics reveal a cancer-associated fibroblast subset in HNSCC that restricts infiltration and antitumor activity of CD8+ T cells. Cancer Res. 2024;84(2):258\u201375. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-1448.","journal-title":"Cancer Res"},{"issue":"1","key":"8160_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-024-01287-7","volume":"16","author":"S Kim","year":"2024","unstructured":"Kim S, Leem G, Choi J, Koh Y, Lee S, Nam S-H, et al. Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis. Genome Med. 2024;16(1):20. https:\/\/doi.org\/10.1186\/s13073-024-01287-7.","journal-title":"Genome Med"},{"issue":"1","key":"8160_CR41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12967-023-04154-y","volume":"21","author":"G Yang","year":"2023","unstructured":"Yang G, Cai S, Hu M, Li C, Yang L, Zhang W, et al. Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer. J Transl Med. 2023;21(1):320. https:\/\/doi.org\/10.1186\/s12967-023-04154-y.","journal-title":"J Transl Med"},{"key":"8160_CR42","doi-asserted-by":"publisher","unstructured":"Parra ER. Methods to determine and analyze the cellular spatial distribution extracted from multiplex immunofluorescence data to understand the tumor microenvironment. Front Mol Biosci. 2021;8:- 2021. https:\/\/doi.org\/10.3389\/fmolb.2021.668340.","DOI":"10.3389\/fmolb.2021.668340"},{"issue":"3","key":"8160_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jbbm.2005.08.001","volume":"64","author":"C Zou","year":"2005","unstructured":"Zou C, Wang Y, Shen Z. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods. 2005;64(3):207\u201315. https:\/\/doi.org\/10.1016\/j.jbbm.2005.08.001.","journal-title":"J Biochem Biophys Methods"},{"key":"8160_CR44","doi-asserted-by":"publisher","unstructured":"D\u2019Souza LJ, Wright SH, Bhattacharya D. Bhattacharya D: genetic evidence that uptake of the fluorescent analog 2NBDG occurs independently of known glucose transporters. PLoS One. 2022;17(8):e0261801. https:\/\/doi.org\/10.1371\/journal.pone.0261801.","DOI":"10.1371\/journal.pone.0261801"},{"key":"8160_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.aca.2020.10.027","volume":"1141","author":"AF Dunn","year":"2021","unstructured":"Dunn AF, Catterton MA, Dixon DD, Pompano RR. Spatially resolved measurement of dynamic glucose uptake in live ex vivo tissues. Analytica (Rome) Acta. 2021;1141:47\u201356. https:\/\/doi.org\/10.1016\/j.aca.2020.10.027.","journal-title":"Analytica (Rome) Acta"},{"key":"8160_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2021.06.017","volume":"190","author":"KE Hamilton","year":"2021","unstructured":"Hamilton KE, Bouwer MF, Louters LL, Looyenga BD. Cellular binding and uptake of fluorescent glucose analogs 2-NBDG and 6-NBDG occurs independent of membrane glucose transporters. Biochimie. 2021;190:1\u201311. https:\/\/doi.org\/10.1016\/j.biochi.2021.06.017.","journal-title":"Biochimie"},{"key":"8160_CR47","doi-asserted-by":"publisher","unstructured":"Sinclair L, Barthelemy C, Cantrell D. Single cell glucose uptake assays: a cautionary tale. Immunometabolism. 2020;2(4):e200029. https:\/\/doi.org\/10.20900\/immunometab20200029.","DOI":"10.20900\/immunometab20200029"},{"key":"8160_CR48","doi-asserted-by":"crossref","unstructured":"Yazdani S, Bilan PJ, Jaldin-Fincati JR, Pang J, Ceban F, Saran E, et al. Dynamic glucose uptake, storage, and release by human microvascular endothelial cells. Mol Biol The Cell. 2022;33:ar106.","DOI":"10.1091\/mbc.E22-04-0146"},{"issue":"17","key":"8160_CR49","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","volume":"184","author":"M Di Pilato","year":"2021","unstructured":"Di Pilato M, Kfuri-Rubens R, Pruessmann JN, Ozga AJ, Messemaker M, Cadilha BL, et al. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell. 2021;184(17):4512\u201330.e22. https:\/\/doi.org\/10.1016\/j.cell.2021.07.015.","journal-title":"Cell"},{"key":"8160_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liang Y, Xu H, Zhang X, Mao T, Cui J, et al. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discov. 2021;7:36.","journal-title":"Cell Discov"},{"issue":"20","key":"8160_CR51","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cmdc.201600276","volume":"11","author":"H Siebeneicher","year":"2016","unstructured":"Siebeneicher H, Cleve A, Rehwinkel H, Neuhaus R, Heisler I, M\u00fcller T, et al. Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876. ChemMedchem. 2016;11(20):2261\u201371. https:\/\/doi.org\/10.1002\/cmdc.201600276.","journal-title":"ChemMedchem"},{"key":"8160_CR52","doi-asserted-by":"publisher","first-page":"113998","DOI":"10.1016\/j.jconrel.2025.113998","volume":"385","author":"Y Wu","year":"2025","unstructured":"Wu Y, Chen W, Deng J, Zhou X, Chen J, Yang Z, et al. Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment. J Control Release. 2025;385:113998. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113998.","journal-title":"J Control Release"},{"key":"8160_CR53","doi-asserted-by":"crossref","unstructured":"Wang J, Qu C, Xiao P, Liu S, Sun J-P, Ping Y-Q. Progress in structure-based drug development targeting chemokine receptors. Front Pharmacol. 2025;16:- 2025.","DOI":"10.3389\/fphar.2025.1603950"},{"key":"8160_CR54","doi-asserted-by":"publisher","first-page":"112015","DOI":"10.1016\/j.intimp.2024.112015","volume":"132","author":"F-T Wang","year":"2024","unstructured":"Wang F-T, Wu T-Q, Lin Y, Jiao Y-R, Li J-Y, Ruan Y, et al. The role of the CXCR6\/CXCL16 axis in the pathogenesis of fibrotic disease. Int Immunopharmacol. 2024;132:112015. https:\/\/doi.org\/10.1016\/j.intimp.2024.112015.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"8160_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1189\/jlb.1003465","volume":"75","author":"T Shimaoka","year":"2004","unstructured":"Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, et al. Cell surface-anchored SR-PSOX\/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol. 2004;75(2):267\u201374. https:\/\/doi.org\/10.1189\/jlb.1003465.","journal-title":"J Leukoc Biol"},{"issue":"8","key":"8160_CR56","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1016\/j.apsb.2022.03.012","volume":"12","author":"T Li","year":"2022","unstructured":"Li T, Pan J, Chen H, Fang Y, Sun Y. CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction. Acta Pharmaceutica Sin. B. 2022;12(8):3255\u201362. https:\/\/doi.org\/10.1016\/j.apsb.2022.03.012.","journal-title":"Acta Pharmaceutica Sin. B"},{"issue":"11","key":"8160_CR57","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41551-021-00737-6","volume":"5","author":"S Lesch","year":"2021","unstructured":"Lesch S, Blumenberg V, Stoiber S, Gottschlich A, Ogonek J, Cadilha BL, et al. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nat Biomed Eng. 2021;5(11):1246\u201360. https:\/\/doi.org\/10.1038\/s41551-021-00737-6.","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"8160_CR58","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","volume":"181","author":"S Matsumura","year":"2008","unstructured":"Matsumura S, Wang B, Kawashima N, Braunstein S, Badura M, Cameron TO, et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol. 2008;181(5):3099\u2013107. https:\/\/doi.org\/10.4049\/jimmunol.181.5.3099.","journal-title":"J Immunol"},{"issue":"4","key":"8160_CR59","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1667\/RR1860.1","volume":"173","author":"S Matsumura","year":"2010","unstructured":"Matsumura S, Demaria S. Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation. Radiat Res. 2010;173(4):418\u201325. https:\/\/doi.org\/10.1667\/RR1860.1.","journal-title":"Radiat Res"},{"issue":"1","key":"8160_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41392-024-02050-5","volume":"10","author":"J Li","year":"2025","unstructured":"Li J, Xiao C, Li C, He J. Tissue-resident immune cells: from defining characteristics to roles in diseases. Sig Transduct Target Ther. 2025;10(1):12. https:\/\/doi.org\/10.1038\/s41392-024-02050-5.","journal-title":"Sig Transduct Target Ther"},{"issue":"5","key":"8160_CR61","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2022.04.008","volume":"40","author":"T Tsuji","year":"2022","unstructured":"Tsuji T, Matsuzaki J, Odunsi K. Tissue residency of memory CD8+ T cells matters in shaping immunogenicity of ovarian cancer. Cancer Cell. 2022;40(5):452\u201354. https:\/\/doi.org\/10.1016\/j.ccell.2022.04.008.","journal-title":"Cancer Cell"},{"key":"8160_CR62","doi-asserted-by":"publisher","unstructured":"Muthuswamy R, McGray AJR, Battaglia S, He W, Miliotto A, Eppolito C, et al. CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer. J Immunother Cancer. 2021;9(10):e003329. https:\/\/doi.org\/10.1136\/jitc-2021-003329.","DOI":"10.1136\/jitc-2021-003329"},{"key":"8160_CR63","doi-asserted-by":"publisher","unstructured":"Wang B, Wang Y, Sun X, Deng G, Huang W, Wu X, et al. CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell. J Immunother Cancer. 2021;9(8):e003100. https:\/\/doi.org\/10.1136\/jitc-2021-003100.","DOI":"10.1136\/jitc-2021-003100"},{"key":"8160_CR64","doi-asserted-by":"crossref","unstructured":"Christian LS, Wang L, Lim B, Deng D, Wu H, Wang X-F, et al. Resident memory T cells in tumor-distant tissues fortify against metastasis formation. Cell Rep. 2021;35.","DOI":"10.1016\/j.celrep.2021.109118"},{"issue":"1","key":"8160_CR65","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B, Wu H, Jiang M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Sig Transduct Target Ther. 2024;9(1):274. https:\/\/doi.org\/10.1038\/s41392-024-01979-x.","journal-title":"Sig Transduct Target Ther"},{"key":"8160_CR66","doi-asserted-by":"publisher","unstructured":"Ouyang P, Wang L, Wu J, Tian Y, Chen C, Li D, et al. Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors. Front Immunol. 2024;15:- 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1344272.","DOI":"10.3389\/fimmu.2024.1344272"},{"issue":"1","key":"8160_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","volume":"24","author":"BH Alsaafeen","year":"2025","unstructured":"Alsaafeen BH, Ali BR, Elkord E. Elkord E: resistance mechanisms to immune checkpoint inhibitors: updated insights. Mol Cancer. 2025;24(1):20. https:\/\/doi.org\/10.1186\/s12943-024-02212-7.","journal-title":"Mol Cancer"},{"issue":"1","key":"8160_CR68","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13(1):80. https:\/\/doi.org\/10.1186\/s40164-024-00543-1.","journal-title":"Exp Hematol Oncol"},{"key":"8160_CR69","doi-asserted-by":"publisher","first-page":"114579","DOI":"10.1016\/j.intimp.2025.114579","volume":"155","author":"J Liu","year":"2025","unstructured":"Liu J, Su Y, Zhang C, Dong H, Yu R, Yang X, et al. NCOA3 impairs the efficacy of anti-PD-L1 therapy via HSP90\u03b1\/EZH2\/CXCL9 axis in colon cancer. Int Immunopharmacol. 2025;155:114579. https:\/\/doi.org\/10.1016\/j.intimp.2025.114579.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"8160_CR70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1.","journal-title":"Nat Rev Cancer"},{"key":"8160_CR71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00262-024-03675-9","volume":"73","author":"KX Yu","year":"2024","unstructured":"Yu KX, Yuan WJ, Wang HZ, Li YX. Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion. Cancer Immunol Immunother. 2024;73:115.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"8160_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40364-025-00883-y","volume":"14","author":"T Zheng","year":"2025","unstructured":"Zheng T, Yu X, Yu C, Xu W, Fan Z, Zhou Y, et al. Tumor-associated endothelial cells in tumor immune escape and immunotherapy: multifaceted roles and treatment approaches. Biomark Res. 2025;14(1):10. https:\/\/doi.org\/10.1186\/s40364-025-00883-y.","journal-title":"Biomark Res"},{"key":"8160_CR73","doi-asserted-by":"publisher","unstructured":"Melssen MM, Sheybani ND, Leick KM, Slingluff CL. Barriers to immune cell infiltration in tumors. J Immunother Cancer. 2023;11(4):e006401. https:\/\/doi.org\/10.1136\/jitc-2022-006401.","DOI":"10.1136\/jitc-2022-006401"},{"issue":"6","key":"8160_CR74","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1007\/s13346-021-01036-y","volume":"11","author":"SW Chung","year":"2021","unstructured":"Chung SW, Xie Y, Suk JS. Overcoming physical stromal barriers to cancer immunotherapy. Drug Deliv Transl Res. 2021;11(6):2430\u201347. https:\/\/doi.org\/10.1007\/s13346-021-01036-y.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"8160_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12967-020-02667-4","volume":"19","author":"V Pietrobon","year":"2021","unstructured":"Pietrobon V, Marincola FM. Hypoxia and the phenomenon of immune exclusion. J Transl Med. 2021;19(1):9. https:\/\/doi.org\/10.1186\/s12967-020-02667-4.","journal-title":"J Transl Med"},{"issue":"2","key":"8160_CR76","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/intimm\/dxh369","volume":"18","author":"T Hara","year":"2006","unstructured":"Hara T, Katakai T, Lee JH, Nambu Y, Nakajima-Nagata N, Gonda H, et al. A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesion. Int Immunol. 2006;18(2):301\u201311. https:\/\/doi.org\/10.1093\/intimm\/dxh369.","journal-title":"Int Immunol"},{"key":"8160_CR77","doi-asserted-by":"crossref","unstructured":"Hussain S, Peng B, Cherian M, Song JW, Ahirwar DK, Ganju RK. The roles of stroma-derived chemokine in different stages of cancer metastases. Front Immunol. 2020;11:- 2020.","DOI":"10.3389\/fimmu.2020.598532"},{"key":"8160_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/478641","volume":"2014","author":"Y Fang","year":"2014","unstructured":"Fang Y, Henderson FC Jr, Yi Q, Lei Q, Li Y, Chen N. Chemokine CXCL16 expression suppresses migration and invasiveness and induces apoptosis in breast cancer cells. Mediators Inflamm. 2014;2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/478641.","journal-title":"Mediators Inflammation"},{"key":"8160_CR79","doi-asserted-by":"publisher","unstructured":"Koenen A, Babendreyer A, Schumacher J, Pasqualon T, Schwarz N, Seifert A, et al. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion. PLoS One. 2017;12(3):e0173486. https:\/\/doi.org\/10.1371\/journal.pone.0173486.","DOI":"10.1371\/journal.pone.0173486"},{"issue":"1","key":"8160_CR80","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12885-015-1446-z","volume":"15","author":"SM Hald","year":"2015","unstructured":"Hald SM, Kiselev Y, Al-Saad S, Richardsen E, Johannessen C, Eilertsen M, et al. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer. 2015;15(1):441. https:\/\/doi.org\/10.1186\/s12885-015-1446-z.","journal-title":"BMC Cancer"},{"issue":"11","key":"8160_CR81","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41577-025-01187-w","volume":"25","author":"E Lanitis","year":"2025","unstructured":"Lanitis E, Irving M, Coukos G. Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy. Nat Rev Immunol. 2025;25(11):831\u201346. https:\/\/doi.org\/10.1038\/s41577-025-01187-w.","journal-title":"Nat Rev Immunol"},{"key":"8160_CR82","doi-asserted-by":"publisher","unstructured":"Nicolas-Boluda A, Vaquero J, Vimeux L, Guilbert T, Barrin S, Kantari-Mimoun C, et al. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. eLife. 2021;10:e58688. https:\/\/doi.org\/10.7554\/eLife.58688.","DOI":"10.7554\/eLife.58688"},{"key":"8160_CR83","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.it.2024.07.009","volume":"45","author":"Y Cho","year":"2024","unstructured":"Cho Y, Doh J. The extracellular matrix in solid tumor immunotherapy. Trends Immunol. 2024;45:705\u201314.","journal-title":"Trends Immunol"},{"key":"8160_CR84","doi-asserted-by":"publisher","unstructured":"Park S, Oh JH, Park DJ, Zhang H, Noh M, Kim Y, et al. CU06-1004-induced vascular normalization improves immunotherapy by Modulating tumor microenvironment via cytotoxic T cells. Front Immunol. 2021;11:- 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.620166.","DOI":"10.3389\/fimmu.2020.620166"},{"issue":"9","key":"8160_CR85","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/s41416-020-1020-6","volume":"123","author":"CJ Hanley","year":"2020","unstructured":"Hanley CJ, Thomas GJ. T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting. Br J Cancer. 2020;123(9):1353\u201355. https:\/\/doi.org\/10.1038\/s41416-020-1020-6.","journal-title":"Br J Cancer"},{"issue":"9","key":"8160_CR86","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3390\/cancers14092314","volume":"14","author":"R Mezzapelle","year":"2022","unstructured":"Mezzapelle R, Leo M, Caprioglio F, Colley LS, Lamarca A, Sabatino L, et al. CXCR4\/CXCL12 activities in the tumor microenvironment and implications for tumor immunotherapy. Cancers. 2022;14(9):2314. https:\/\/doi.org\/10.3390\/cancers14092314.","journal-title":"Cancers"},{"issue":"1","key":"8160_CR87","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/imr.12982","volume":"302","author":"M Desbois","year":"2021","unstructured":"Desbois M, Wang Y. Cancer-associated fibroblasts: key players in shaping the tumor immune microenvironment. Immunological Rev. 2021;302(1):241\u201358. https:\/\/doi.org\/10.1111\/imr.12982.","journal-title":"Immunological Rev"},{"key":"8160_CR88","doi-asserted-by":"publisher","unstructured":"Koppensteiner L, Mathieson L, O\u2019Connor RA, Akram AR. Cancer associated fibroblasts - an impediment to effective anti-cancer T cell immunity. Front. Immunol. 2022;13:- 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.887380.","DOI":"10.3389\/fimmu.2022.887380"},{"key":"8160_CR89","doi-asserted-by":"crossref","unstructured":"Chen C IX, Posada VP, Ng J, Wu MR, Adstamongkonkul MW, Huang P, et al. Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proceedings of the National Academy of Sciences. 2019: 4558\u201366, 116.","DOI":"10.1073\/pnas.1815515116"},{"issue":"6","key":"8160_CR90","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.4049\/jimmunol.172.6.3678","volume":"172","author":"PJ Gough","year":"2004","unstructured":"Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol. 2004;172(6):3678\u201385. https:\/\/doi.org\/10.4049\/jimmunol.172.6.3678.","journal-title":"J Immunol"},{"issue":"12","key":"8160_CR91","doi-asserted-by":"publisher","first-page":"8064","DOI":"10.4049\/jimmunol.178.12.8064","volume":"178","author":"C Hundhausen","year":"2007","unstructured":"Hundhausen C, Schulte A, Schulz B, Andrzejewski MG, Schwarz N, von Hundelshausen P, et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol. 2007;178(12):8064\u201372. https:\/\/doi.org\/10.4049\/jimmunol.178.12.8064.","journal-title":"J Immunol"},{"issue":"1","key":"8160_CR92","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41698-024-00671-1","volume":"8","author":"HL Williams","year":"2024","unstructured":"Williams HL, Frei AL, Koessler T, Berger MD, Dawson H, Michielin O, et al. The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibition. Npj Precis Onc. 2024;8(1):178. https:\/\/doi.org\/10.1038\/s41698-024-00671-1.","journal-title":"Npj Precis Onc"},{"issue":"3","key":"8160_CR93","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1172\/jci.insight.145789","volume":"6","author":"M Tang","year":"2021","unstructured":"Tang M, Park SH, Petri S, Yu H, Rueda CB, Abel ED, et al. An early endothelial cell\u2013specific requirement for Glut1 is revealed in Glut1 deficiency syndrome model mice. JCI Insight. 2021;6(3):6. https:\/\/doi.org\/10.1172\/jci.insight.145789.","journal-title":"JCI Insight"},{"issue":"2","key":"8160_CR94","doi-asserted-by":"publisher","first-page":"166967","DOI":"10.1016\/j.bbadis.2023.166967","volume":"1870","author":"JCS Chaves","year":"2024","unstructured":"Chaves JCS, Dando SJ, White AR, Oikari LE. Blood-brain barrier transporters: an overview of function, dysfunction in Alzheimer\u2019s disease and strategies for treatment. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2024;1870(2):166967. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166967.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"key":"8160_CR95","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yebeh.2018.06.010","volume":"91","author":"H Koch","year":"2019","unstructured":"Koch H, Weber YG. The glucose transporter type 1 (Glut1) syndromes. Epilepsy Behav. 2019;91:90\u201393. https:\/\/doi.org\/10.1016\/j.yebeh.2018.06.010.","journal-title":"Epilepsy Behav"},{"key":"8160_CR96","doi-asserted-by":"publisher","first-page":"175552","DOI":"10.1016\/j.ejphar.2023.175552","volume":"945","author":"Z Chen","year":"2023","unstructured":"Chen Z, Vaeth M, Eckstein M, Delgobo M, Ramos G, Frantz S, et al. Characterization of the effect of the GLUT-1 inhibitor BAY-876 on T cells and macrophages. Eur J Pharmacol. 2023;945:175552. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175552.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"8160_CR97","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1038\/s41467-023-37727-y","volume":"14","author":"B Palakurthi","year":"2023","unstructured":"Palakurthi B, Fross SR, Guldner IH, Aleksandrovic E, Liu X, Martino AK, et al. Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Nat Commun. 2023;14(1):2109. https:\/\/doi.org\/10.1038\/s41467-023-37727-y.","journal-title":"Nat Commun"},{"key":"8160_CR98","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1084\/jem.20181308","volume":"216","author":"AN Wein","year":"2019","unstructured":"Wein AN, McMaster SR, Takamura S, Dunbar PR, Cartwright EK, Hayward SL, et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways. J Exp Med. 2019;216:2748\u201362.","journal-title":"J Exp Med"},{"issue":"23","key":"8160_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers17233818","volume":"17","author":"M Reeves","year":"2025","unstructured":"Reeves M, Chambers A, Shrestha A, Duarte S, Zarrinpar A, Malany S, et al. Targeting CXCR6 disrupts \u03b2-catenin signaling and enhances sorafenib response in hepatocellular carcinoma. Cancers (Basel). 2025;17(23):17. https:\/\/doi.org\/10.3390\/cancers17233818.","journal-title":"Cancers (Basel)"},{"issue":"14","key":"8160_CR100","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1158\/0008-5472.CAN-11-4032","volume":"72","author":"Q Gao","year":"2012","unstructured":"Gao Q, Zhao Y-J, Wang X-Y, Qiu S-J, Shi Y-H, Sun J, et al. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Res. 2012;72(14):3546\u201356. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-4032.","journal-title":"Cancer Res"},{"issue":"1","key":"8160_CR101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13073-025-01498-6","volume":"17","author":"IN Lu","year":"2025","unstructured":"Lu IN, M\u00fcller-Miny L, Krekeler C, Cheung PF-Y, Antonopoulou G, Jeibmann A, et al. The CXCL16\/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy. Genome Med. 2025;17(1):71. https:\/\/doi.org\/10.1186\/s13073-025-01498-6.","journal-title":"Genome Med"},{"issue":"5","key":"8160_CR102","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","volume":"15","author":"Z Mai","year":"2024","unstructured":"Mai Z, Lin Y, Lin P, Zhao X, Cui L. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024;15(5):307. https:\/\/doi.org\/10.1038\/s41419-024-06697-4.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8160_CR103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","volume":"18","author":"Q Hu","year":"2025","unstructured":"Hu Q, Zhu Y, Mei J, Liu Y, Zhou G. Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy. J Hematol Oncol. 2025;18(1):65. https:\/\/doi.org\/10.1186\/s13045-025-01717-y.","journal-title":"J Hematol Oncol"},{"key":"8160_CR104","doi-asserted-by":"publisher","first-page":"1387198","DOI":"10.3389\/fcell.2024.1387198","volume":"12","author":"Y Xu","year":"2024","unstructured":"Xu Y, Miller CP, Tykodi SS, Akilesh S, Warren EH. Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors. Front. Cell Dev. Biol. 2024;12:1387198. https:\/\/doi.org\/10.3389\/fcell.2024.1387198.","journal-title":"Front. Cell Dev. Biol"},{"issue":"5","key":"8160_CR105","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;54(5):859\u201374. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.012.","journal-title":"Immunity"},{"issue":"16","key":"8160_CR106","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22168530","volume":"22","author":"S Kadomoto","year":"2021","unstructured":"Kadomoto S, Izumi K, Mizokami A. Roles of CCL2-CCR2 axis in the tumor microenvironment. IJMS. 2021;22(16):22. https:\/\/doi.org\/10.3390\/ijms22168530.","journal-title":"IJMS"},{"key":"8160_CR107","doi-asserted-by":"publisher","first-page":"115318","DOI":"10.1016\/j.addr.2024.115318","volume":"209","author":"S Pozzi","year":"2024","unstructured":"Pozzi S, Satchi-Fainaro R. The role of CCL2\/CCR2 axis in cancer and inflammation: the next frontier in nanomedicine. Adv Drug Deliv Rev. 2024;209:115318. https:\/\/doi.org\/10.1016\/j.addr.2024.115318.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"8160_CR108","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cancers12071765","volume":"12","author":"D Aldinucci","year":"2020","unstructured":"Aldinucci D, Borghese C, Casagrande N. The CCL5\/CCR5 axis in cancer progression. Cancers (Basel). 2020;12(7):12. https:\/\/doi.org\/10.3390\/cancers12071765.","journal-title":"Cancers (Basel)"},{"key":"8160_CR109","doi-asserted-by":"publisher","unstructured":"Roller A, Davydov II II, Schwalie PC, Serrano-Serrano ML, Heller A, Staedler N, et al. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials. J Immunother Cancer. 2024;12(4):e008185. https:\/\/doi.org\/10.1136\/jitc-2023-008185.","DOI":"10.1136\/jitc-2023-008185"},{"issue":"2","key":"8160_CR110","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","volume":"19","author":"G Palla","year":"2022","unstructured":"Palla G, Spitzer H, Klein M, Fischer D, Schaar AC, Kuemmerle LB, et al. Squidpy: a scalable framework for spatial omics analysis. Nat Methods. 2022;19(2):171\u201378. https:\/\/doi.org\/10.1038\/s41592-021-01358-2.","journal-title":"Nat Methods"},{"key":"8160_CR111","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","volume":"57","author":"O Mfd","year":"2025","unstructured":"Mfd O, Romero JP, Chung M, Williams SR, Gottscho AD, Gupta A, et al. High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat Genet. 2025;57:1512\u201323.","journal-title":"Nat Genet"},{"issue":"7","key":"8160_CR112","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.celrep.2024.114392","volume":"43","author":"C Quek","year":"2024","unstructured":"Quek C, Pratapa A, Bai X, Al-Eryani G, Pires da Silva I, Mayer A, et al. Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy. Cell Rep. 2024;43(7):43. https:\/\/doi.org\/10.1016\/j.celrep.2024.114392.","journal-title":"Cell Rep"},{"issue":"1","key":"8160_CR113","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41698-025-00857-1","volume":"9","author":"S-Y Jing","year":"2025","unstructured":"Jing S-Y, Wang H-Q, Lin P, Yuan J, Tang Z-X, Li H. Li H: quantifying and interpreting biologically meaningful spatial signatures within tumor microenvironments. Npj Precis Onc. 2025;9(1):68. https:\/\/doi.org\/10.1038\/s41698-025-00857-1.","journal-title":"Npj Precis Onc"},{"key":"8160_CR114","doi-asserted-by":"publisher","unstructured":"Taube JM, Sunshine JC, Angelo M, Akturk G, Eminizer M, Engle LL, et al. Society for immunotherapy of cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing. J Immunother Cancer. 2025;13(1):e008875. https:\/\/doi.org\/10.1136\/jitc-2024-008875.","DOI":"10.1136\/jitc-2024-008875"},{"key":"8160_CR115","doi-asserted-by":"publisher","unstructured":"Kumar G, Pandurengan RK, Parra ER, Kannan K, Haymaker C. Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications. Front Immunol. 2023;14:- 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1288802.","DOI":"10.3389\/fimmu.2023.1288802"},{"key":"8160_CR116","doi-asserted-by":"publisher","unstructured":"Liu F, Li G, Zheng Y, Liu Y, Liu K. Multiplex imaging analysis of the tumor immune microenvironment for guiding precision immunotherapy. Front. Immunol. 2025;16:- 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1617906.","DOI":"10.3389\/fimmu.2025.1617906"},{"issue":"5","key":"8160_CR117","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41590-025-02134-6","volume":"26","author":"M Shakiba","year":"2025","unstructured":"Shakiba M, Tuveson DA. Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer. Nat Immunol. 2025;26(5):678\u201391. https:\/\/doi.org\/10.1038\/s41590-025-02134-6.","journal-title":"Nat Immunol"},{"issue":"7","key":"8160_CR118","doi-asserted-by":"publisher","first-page":"101640","DOI":"10.1016\/j.xcrm.2024.101640","volume":"5","author":"K Tooley","year":"2024","unstructured":"Tooley K, Jerby L, Escobar G, Krovi SH, Mangani D, Dandekar G, et al. Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1: CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity. Cell Rep Med. 2024;5(7):101640. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101640.","journal-title":"Cell Rep. Med"},{"issue":"1","key":"8160_CR119","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1038\/s41467-023-37807-z","volume":"14","author":"DJ Kim","year":"2023","unstructured":"Kim DJ, Anandh S, Null JL, Przanowski P, Bhatnagar S, Kumar P, et al. Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors. Nat Commun. 2023;14(1):2122. https:\/\/doi.org\/10.1038\/s41467-023-37807-z.","journal-title":"Nat Commun"},{"key":"8160_CR120","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14:54.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"8160_CR121","doi-asserted-by":"publisher","first-page":"100543","DOI":"10.1016\/j.xcrm.2022.100543","volume":"3","author":"J Foeng","year":"2022","unstructured":"Foeng J, Comerford I, McColl SR. Harnessing the chemokine system to home CAR-T cells into solid tumors. Cell Rep Med. 2022;3(3):100543. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100543.","journal-title":"Cell Rep. Med"},{"issue":"19","key":"8160_CR122","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1158\/1078-0432.CCR-23-3298","volume":"30","author":"LJ Talbot","year":"2024","unstructured":"Talbot LJ, Chabot A, Ross AB, Beckett A, Nguyen P, Fleming A, et al. Redirecting B7-H3.CAR T cells to chemokines expressed in Osteosarcoma enhances homing and antitumor activity in preclinical models. Clin Cancer Res. 2024;30(19):4434\u201349. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-3298.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"8160_CR123","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1158\/2326-6066.CIR-22-0593","volume":"11","author":"R Yan","year":"2023","unstructured":"Yan R, Moresco P, Gegenhuber B, Fearon DT. T cell\u2013mediated development of stromal fibroblasts with an immune-enhancing chemokine profile. Cancer Immunol Res. 2023;11(8):1044\u201354. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0593.","journal-title":"Cancer Immunol Res"},{"key":"8160_CR124","doi-asserted-by":"publisher","unstructured":"Battaglin F, Baca Y, Millstein J, Yang Y, Xiu J, Arai H, et al. CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value. J Immunother Cancer. 2024;12(1):e007939. https:\/\/doi.org\/10.1136\/jitc-2023-007939.","DOI":"10.1136\/jitc-2023-007939"},{"issue":"1","key":"8160_CR125","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Sig Transduct Target Ther. 2024;9(1):176. https:\/\/doi.org\/10.1038\/s41392-024-01868-3.","journal-title":"Sig Transduct Target Ther"},{"key":"8160_CR126","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cjprs.2025.05.001","volume":"7","author":"H Chen","year":"2025","unstructured":"Chen H, Li Q. Recent advances in scalable exosome production: challenges and innovations. Chin J Plast Reconstructive Surg. 2025;7:149\u201363.","journal-title":"Chin J Plast Reconstructive Surg"},{"issue":"8","key":"8160_CR127","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/pharmaceutics17080990","volume":"17","author":"N Verma","year":"2025","unstructured":"Verma N, Arora S. Navigating the global regulatory landscape for exosome-based therapeutics: challenges, strategies, and Future directions. Pharmaceutics. 2025;17(8):990. https:\/\/doi.org\/10.3390\/pharmaceutics17080990.","journal-title":"Pharmaceutics"},{"issue":"4","key":"8160_CR128","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hcs2.70028","volume":"4","author":"Q Li","year":"2025","unstructured":"Li Q, Li Y, Shao J, Sun J, Hu L, Yun X, et al. Exploring regulatory frameworks for exosome therapy: insights and perspectives. Health Care (Don Mills) Sci. 2025;4(4):299\u2013309. https:\/\/doi.org\/10.1002\/hcs2.70028.","journal-title":"Health Care (Don Mills) Sci"},{"key":"8160_CR129","doi-asserted-by":"crossref","unstructured":"Wang C-K, Tsai T-H, Lee C-H. Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024;17:e13904.","DOI":"10.1111\/cts.13904"},{"key":"8160_CR130","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41467-026-69456-3","volume":"17","author":"M Yi","year":"2026","unstructured":"Yi M, Li T, Gu Y, Niu M, Xue D, Hu S, et al. Triple targeting of STING, TGF-\u03b2, and PD-L1 boosts CXCL16-CXCR6 signaling for potent antitumor response. Nat Commun. 2026;17:1441.","journal-title":"Nat Commun"},{"issue":"5","key":"8160_CR131","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/path.6165","volume":"260","author":"DB Page","year":"2023","unstructured":"Page DB, Broeckx G, Jahangir CA, Verbandt S, Gupta RR, Thagaard J, et al. Spatial analyses of immune cell infiltration in cancer: current methods and future directions: a report of the International Immuno-Oncology biomarker working group on breast cancer. The J Pathol. 2023;260(5):514\u201332. https:\/\/doi.org\/10.1002\/path.6165.","journal-title":"The J Pathol"},{"issue":"3","key":"8160_CR132","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396. https:\/\/doi.org\/10.1084\/jem.20162024.","journal-title":"J Exp Med"},{"issue":"8","key":"8160_CR133","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9(8):1102\u201323. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0094.","journal-title":"Cancer Discov"},{"issue":"1","key":"8160_CR134","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","volume":"9","author":"M Bartoschek","year":"2018","unstructured":"Bartoschek M, Oskolkov N, Bocci M, L\u00f6vrot J, Larsson C, Sommarin M, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018;9(1):5150. https:\/\/doi.org\/10.1038\/s41467-018-07582-3.","journal-title":"Nat Commun"},{"key":"8160_CR135","doi-asserted-by":"publisher","unstructured":"Miyai Y, Sugiyama D, Hase T, Asai N, Taki T, Nishida K, et al. Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade. Life Sci Alliance. 2022;5(6):e202101230. https:\/\/doi.org\/10.26508\/lsa.202101230.","DOI":"10.26508\/lsa.202101230"},{"issue":"1","key":"8160_CR136","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","volume":"14","author":"L Cords","year":"2023","unstructured":"Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, et al. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023;14(1):4294. https:\/\/doi.org\/10.1038\/s41467-023-39762-1.","journal-title":"Nat Commun"},{"issue":"24","key":"8160_CR137","doi-asserted-by":"publisher","first-page":"13408","DOI":"10.3390\/ijms222413408","volume":"22","author":"U Vaish","year":"2021","unstructured":"Vaish U, Jain T, Are AC, Dudeja V. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma: an update on heterogeneity and therapeutic targeting. IJMS. 2021;22(24):13408. https:\/\/doi.org\/10.3390\/ijms222413408.","journal-title":"IJMS"},{"issue":"1","key":"8160_CR138","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, Wei R, Liu C, Zhao Z, Liu X, Wang Y, et al. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response. Nat Commun. 2025;16(1):2175. https:\/\/doi.org\/10.1038\/s41467-025-57465-7.","journal-title":"Nat Commun"},{"key":"8160_CR139","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13046-023-02934-4","volume":"42","author":"R Melchionna","year":"2023","unstructured":"Melchionna R, Trono P, Di Carlo A, Di Modugno F, Nistic\u00f2 P. Transcription factors in fibroblast plasticity and CAF heterogeneity. J Exp Clin Cancer Res. 2023;42:347.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"8160_CR140","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-021-01949-z","volume":"40","author":"X Yan","year":"2021","unstructured":"Yan X, Xie Y, Yang F, Hua Y, Zeng T, Sun C, et al. Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis. J Exp Clin Cancer Res. 2021;40(1):142. https:\/\/doi.org\/10.1186\/s13046-021-01949-z.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"8160_CR141","doi-asserted-by":"publisher","first-page":"189316","DOI":"10.1016\/j.bbcan.2025.189316","volume":"1880","author":"R Pe\u00f1a","year":"2025","unstructured":"Pe\u00f1a R, Baulida J. Snail1 as a key prognostic biomarker of cancer-associated fibroblasts in breast tumors. Biochim et Biophys Acta (BBA) - Rev Cancer. 2025;1880(3):189316. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189316.","journal-title":"Biochim et Biophys Acta (BBA) - Rev Cancer"},{"issue":"2","key":"8160_CR142","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41416-024-02734-3","volume":"131","author":"T Owaki","year":"2024","unstructured":"Owaki T, Iida T, Miyai Y, Kato K, Hase T, Ishii M, et al. Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade. Br J Cancer. 2024;131(2):372\u201386. https:\/\/doi.org\/10.1038\/s41416-024-02734-3.","journal-title":"Br J Cancer"},{"issue":"7934","key":"8160_CR143","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","volume":"611","author":"AT Krishnamurty","year":"2022","unstructured":"Krishnamurty AT, Shyer JA, Thai M, Gandham V, Buechler MB, Yang YA, et al. LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature. 2022;611(7934):148\u201354. https:\/\/doi.org\/10.1038\/s41586-022-05272-1.","journal-title":"Nature"},{"key":"8160_CR144","doi-asserted-by":"publisher","first-page":"102251","DOI":"10.1016\/j.xcrm.2025.102251","volume":"6","author":"L Huang","year":"2025","unstructured":"Huang L, Lu W, Wu R, Li Y, Ou Z, Chen J, et al. Interferon-driven CAF reprogramming augments immunogenic response to neoadjuvant radiotherapy in colorectal cancer. Cell Rep. Med. 2025;6:102251.","journal-title":"Cell Rep. Med"},{"issue":"12","key":"8160_CR145","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, et al. Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40(12):1550\u201365.e7. https:\/\/doi.org\/10.1016\/j.ccell.2022.11.005.","journal-title":"Cancer Cell"},{"key":"8160_CR146","doi-asserted-by":"publisher","unstructured":"Wu C, Gu J, Gu H, Zhang X, Zhang X, Ji R. The recent advances of cancer associated fibroblasts in cancer progression and therapy. Front Oncol. 2022;12:- 2022. https:\/\/doi.org\/10.3389\/fonc.2022.1008843.","DOI":"10.3389\/fonc.2022.1008843"},{"key":"8160_CR147","doi-asserted-by":"publisher","unstructured":"Ning L, Quan C, Wang Y, Wu Z, Yuan P, Xie N. scRNA-seq characterizing the heterogeneity of fibroblasts in breast cancer reveals a novel subtype SFRP4+ CAF that inhibits migration and predicts prognosis. Front Oncol. 2024;14:- 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1348299.","DOI":"10.3389\/fonc.2024.1348299"},{"issue":"1","key":"8160_CR148","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1038\/s41467-022-33619-9","volume":"13","author":"C Zuo","year":"2022","unstructured":"Zuo C, Zhang Y, Cao C, Feng J, Jiao M, Chen L. Elucidating tumor heterogeneity from spatially resolved transcriptomics data by multi-view graph collaborative learning. Nat Commun. 2022;13(1):5962. https:\/\/doi.org\/10.1038\/s41467-022-33619-9.","journal-title":"Nat Commun"},{"issue":"8","key":"8160_CR149","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","volume":"186","author":"Y Chhabra","year":"2023","unstructured":"Chhabra Y, Weeraratna AT. Fibroblasts in cancer: unity in heterogeneity. Cell. 2023;186(8):1580\u2013609. https:\/\/doi.org\/10.1016\/j.cell.2023.03.016.","journal-title":"Cell"},{"issue":"1","key":"8160_CR150","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, Xia X, Huang L-B, An H, Cao M, Kim GD, et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 2022;13(1):6619. https:\/\/doi.org\/10.1038\/s41467-022-34395-2.","journal-title":"Nat Commun"},{"issue":"1","key":"8160_CR151","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101(1):147\u201376. https:\/\/doi.org\/10.1152\/physrev.00048.2019.","journal-title":"Physiol Rev"},{"issue":"1","key":"8160_CR152","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","volume":"42","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Yu Y, Zhang Z, Li D, Liang Z, Wang L, et al. Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1. J Exp Clin Cancer Res. 2023;42(1):316. https:\/\/doi.org\/10.1186\/s13046-023-02900-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"8160_CR153","doi-asserted-by":"publisher","first-page":"117045","DOI":"10.1016\/j.biopha.2024.117045","volume":"177","author":"M Chen","year":"2024","unstructured":"Chen M, Chen F, Gao Z, Li X, Hu L, Yang S, et al. Cafs and T cells interplay: the emergence of a new arena in cancer combat. Biomed Pharmacother. 2024;177:117045. https:\/\/doi.org\/10.1016\/j.biopha.2024.117045.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8160_CR154","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12964-025-02138-7","volume":"23","author":"L Zheng","year":"2025","unstructured":"Zheng L, Cai W, Ke Y, Hu X, Yang C, Zhang R, et al. Cancer\u2011associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy. Cell Commun Signal. 2025;23(1):147. https:\/\/doi.org\/10.1186\/s12964-025-02138-7.","journal-title":"Cell Commun Signal"},{"key":"8160_CR155","doi-asserted-by":"publisher","first-page":"109038","DOI":"10.1016\/j.jnutbio.2022.109038","volume":"107","author":"C Jia","year":"2022","unstructured":"Jia C, Zhao Y, Huang H, Fan K, Xie T, Xie M. Apigenin sensitizes radiotherapy of mouse subcutaneous glioma through attenuations of cell stemness and DNA damage repair by inhibiting NF-\u03baB\/HIF-1\u03b1-mediated glycolysis. The J Nutritional Biochem. 2022;107:109038. https:\/\/doi.org\/10.1016\/j.jnutbio.2022.109038.","journal-title":"The J Nutritional Biochem"},{"issue":"12","key":"8160_CR156","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/apm.13447","volume":"132","author":"S Ahuja","year":"2024","unstructured":"Ahuja S, Sureka N, Zaheer S. Unraveling the intricacies of cancer-associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalk. APMIS. 2024;132(12):906\u201327. https:\/\/doi.org\/10.1111\/apm.13447.","journal-title":"APMIS"},{"issue":"14","key":"8160_CR157","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.3390\/cancers14143321","volume":"14","author":"I Kim","year":"2022","unstructured":"Kim I, Choi S, Yoo S, Lee M, Kim I-S. Cancer-associated fibroblasts in the hypoxic tumor microenvironment. Cancers. 2022;14(14):3321. https:\/\/doi.org\/10.3390\/cancers14143321.","journal-title":"Cancers"},{"issue":"1","key":"8160_CR158","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s11658-024-00682-7","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J, Yao M, Xia S, Zeng F, Liu Q. Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer. Cell Mol Biol Lett. 2025;30(1):2. https:\/\/doi.org\/10.1186\/s11658-024-00682-7.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"8160_CR159","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-physchem-061020-053416","volume":"72","author":"D Unsihuay","year":"2021","unstructured":"Unsihuay D, Mesa Sanchez D, Laskin J. Quantitative mass spectrometry imaging of biological systems. Annu Rev Phys Chem. 2021;72(1):307\u201329. https:\/\/doi.org\/10.1146\/annurev-physchem-061020-053416.","journal-title":"Annu Rev Phys Chem"},{"key":"8160_CR160","doi-asserted-by":"publisher","first-page":"340241","DOI":"10.1016\/j.aca.2022.340241","volume":"1225","author":"Y Han","year":"2022","unstructured":"Han Y, Zhao Y, Chen P, Wang L, Hu Q, Wang X, et al. On-tissue derivatization for isomer-specific mass spectrometry imaging and relative quantification of monosaccharides in biological tissues. Analytica (Rome) Acta. 2022;1225:340241. https:\/\/doi.org\/10.1016\/j.aca.2022.340241.","journal-title":"Analytica (Rome) Acta"},{"issue":"28","key":"8160_CR161","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1007\/s00216-024-05559-4","volume":"416","author":"E Nagano","year":"2024","unstructured":"Nagano E, Odake K, Shimma S. Tissue derivatization for visualizing lactate and pyruvate in mouse testis tissues using matrix-assisted laser desorption\/ionization-mass spectrometry imaging. Anal Bioanal Chem. 2024;416(28):6601\u201310. https:\/\/doi.org\/10.1007\/s00216-024-05559-4.","journal-title":"Anal Bioanal Chem"},{"issue":"10","key":"8160_CR162","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/s41592-024-02392-6","volume":"21","author":"JB Nunes","year":"2024","unstructured":"Nunes JB, Ijsselsteijn ME, Abdelaal T, Ursem R, van der Ploeg M, Giera M, et al. Integration of mass cytometry and mass spectrometry imaging for spatially resolved single-cell metabolic profiling. Nat Methods. 2024;21(10):1796\u2013800. https:\/\/doi.org\/10.1038\/s41592-024-02392-6.","journal-title":"Nat Methods"},{"issue":"4","key":"8160_CR163","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","volume":"11","author":"C Giesen","year":"2014","unstructured":"Giesen C, Wang HAO, Schapiro D, Zivanovic N, Jacobs A, Hattendorf B, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods. 2014;11(4):417\u201322. https:\/\/doi.org\/10.1038\/nmeth.2869.","journal-title":"Nat Methods"},{"issue":"8","key":"8160_CR164","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1038\/s41596-021-00556-8","volume":"16","author":"S Black","year":"2021","unstructured":"Black S, Phillips D, Hickey JW, Kennedy-Darling J, Venkataraaman VG, Samusik N, et al. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat Protoc. 2021;16(8):3802\u201335. https:\/\/doi.org\/10.1038\/s41596-021-00556-8.","journal-title":"Nat Protoc"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08160-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08160-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08160-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:38:14Z","timestamp":1783899494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08160-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":164,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8160"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08160-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"888"}}